← boothcheck

Is MDLZ overvalued?

boothcheck doesn't label MDLZ overvalued or undervalued and publishes no house fair value, target price, or buy/sell rating. Individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. In the published model solve dated 2026-08-30T04:06:24.299Z, anchored at $62.16, MDLZ is priced for growth of +8.9%. The price is justified by relative-multiple; asset-based/earnings-power land below the price. The report narrative was composed 2026-07-03. The more the price assumes beyond what Mondelez International, Inc. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from Mondelez International, Inc.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed July 3, 2026.

Implied growth+8.9%
For about
Held margin (input)
Margin today
Price vs asset value2.71x
Price vs earnings power3.06x
Price vs peer multiples1.19x
Price vs forward growth1.32x
Read the full MDLZ report →
Get boothcheck's read on what MDLZ's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.